← Home / Instil Bio, Inc. (TIL)
Stock Analysis

Instil Bio, Inc. (TIL)

TIL
TIL · Healthcare • Biotechnology
7.88 +3.68%
Track TIL in your personal workspace Monitor performance, SPY relative strength and WOI View from your watchlist.
Alert me when TIL price is:
52W Range Position
5%
LOWMIDHIGH
Trend
Mixed
Momentum
Neutral
Updated: 2026-08-27 04:11 UTC
WOI Investment Thesis
Mixed
Current market structure would strengthen above 8.04. Holding above 7.58 preserves the current price structure.
⚖️
✓
Fundamentals
Negative / Mixed / Manageable
✓
Price Structure
Mixed
•
Momentum
Neutral
×
Current Resistance
Below Resistance
Risk Level
Moderate
Analysis Scope
1Y Daily
Key Decision Levels
✓
Hold Above
Structure remains valid above support.
7.58
↗
Break Above
No setup-specific trigger is available; nearest structural resistance is shown.
8.04
🎯
Next Objective
No defined objective is currently available for the primary technical setup.
Not available
×
Thesis Break
No setup-specific invalidation level is currently defined.
Not available
Recent Company Events
SEC VERIFIED
Latest material filings
AUG
13
●
Financial Results
HIGH
TIL reports financial results
On August 13, 2026 , Instil Bio, Inc.
8-K Filing • SEC EDGAR
MAY
15
●
Financial Results
HIGH
Instil Bio Reports First Quarter 2026 Financial Results and
(“Instil”) (Nasdaq: TIL), a biotechnology company focused on identifying and advancing innovative therapeutics, today reported its first quarter 2026 financial results and provided a corporate update.
8-K Filing • SEC EDGAR
What's Driving TIL?
• No active technical setup
Momentum is Neutral. No qualified technical setup is currently active.
◆ Business quality is mixed
Profitability is negative. Cash generation is mixed. Balance-sheet quality is manageable.
⚠️ Key risk remains
losing 7.58 would weaken the current structure.
Full Analysis Workspace
Technical Signal
No Active Technical Setup
•
No qualified technical setup is currently active.
RSI(14)
64.5
◎
How to read this setup
The next meaningful technical decision is likely to occur between support at 7.58 and resistance at 8.04. Clearing resistance would strengthen the constructive case, while a failure through support would damage the present setup.
Price Chart
TIL — 1D Chart
Open Full Workspace
Valuation Snapshot (TTM)
Full valuation · Ratios use trailing twelve months
Updated 2026-08-26
Fair
Fair valuation
Valuation looks broadly balanced relative to current fundamentals.
Market Cap
$51.5M
Company size
EV
$69.3M
Debt-adjusted value
P/B
0.5
Low book multiple
EV/EBIT
-1.9
Not meaningful
P/FCF
0.6
Low multiple
Not financial advice
Business Lens
Financial context is mixed
Financial quality is mixed, with cash flow or balance sheet items requiring closer monitoring.
↗
Revenue Growth
Mixed
●
Profitability
Negative
≈
Cash Flow
Mixed
⚖
Balance Sheet
Manageable
💵 Revenue
0.00
≈ Mixed
📈 Net Income
-4.30M
↘ Negative
🧮 EPS (Basic)
-0.63
↘ Negative
Instil Bio, Inc.
Healthcare • Biotechnology
You Might Also Like